ITGAM and neoplasm: Supernatants from tumor- or spleen-derived CD11b+ cells of MT/ret mice also reduced the proportions of IFNγ secreting T cells (49% and 40% inhibition respectively), while supernatant from control mice had no effect (Fig. 4A, lower histogram).